Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
3.830
+0.050 (1.32%)
At close: Jul 24, 2026, 4:00 PM EDT
3.794
-0.036 (-0.94%)
After-hours: Jul 24, 2026, 7:57 PM EDT
Plus Therapeutics Stock Forecast
PSTV's stock price has decreased by -68.73% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 4 analysts polled by S&P Global, Plus Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $36. The average 1-year stock price forecast is 839.95% higher than the current stock price, while the lowest is $12 (+213.32%) and the highest is $57 (+1,388.25%).
Price Target: $36 (+839.95%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Plus Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Buy Reiterates $50 | Buy | Reiterates | $50 | +1,205.48% | Jul 1, 2026 |
| Ascendiant | Ascendiant | Buy Maintains $65 → $57 | Buy | Maintains | $65 → $57 | +1,388.25% | Jun 6, 2026 |
| Maxim Group | Maxim Group | Buy Maintains $12 | Buy | Maintains | $12 | +213.32% | May 20, 2026 |
| D. Boral Capital | D. Boral Capital | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Mar 31, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $25 | Buy | Reiterates | $25 | +552.74% | Mar 16, 2026 |
Financial Forecast
Revenue This Year
6.30M
from 5.21M
Increased by 20.76%
Revenue Next Year
19.14M
from 6.30M
Increased by 204.05%
EPS This Year
-3.92
from -0.29
EPS Next Year
-2.40
from -3.92
EPS and Forward PE are based on non-GAAP adjusted numbers.